POINT Biopharma Global Current Cash

POINT Biopharma Global (PNT) currently reports a current cash of $22M as of September 2023. That compares with $290M in the prior-year period — down 92.6% year over year. Use the charts on this page to explore POINT Biopharma Global's current cash history and peer comparisons.

POINT Biopharma Global's current cash decreased from $290M to $22M — a 92.6% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

POINT Biopharma Global reported $22M in current cash as of September 2023. That compares with $290M in the prior-year period — down 92.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for POINT Biopharma Global, and consider following PNT for alerts when major investors trade the stock.

POINT Biopharma Global is classified in the Healthcare sector. On current cash, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PNT with unrelated industries.